<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Shinn RL</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>American College of Veterinary Internal Medicine</funding><pagination>2021-2028</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7517515</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Stereotactic brain biopsy (SBB) allows for histopathologic diagnosis of brain tumors. Adverse events (AE) occur in 5 to 29% of dogs after SBB, but risk factors associated with developing AE are poorly described.&lt;h4>Objective&lt;/h4>Identify clinicopathologic, diagnostic imaging, or procedural variables that are associated with AE in dogs after SBB.&lt;h4>Animals&lt;/h4>Twenty-nine dogs with brain tumors.&lt;h4>Methods&lt;/h4>Retrospective, case-control study. Dogs had laboratory investigations performed before SBB, as well as clinical examinations and diagnostic imaging of the brain before and after SBB. Cases experienced AE after SBB including transient exacerbation of preexisting neurologic deficits, transient new deficits, or permanent neurologic deficits. Controls had SBB performed</pubmed_abstract><journal>Journal of veterinary internal medicine</journal><pubmed_title>Risk factors for adverse events occurring after recovery from stereotactic brain biopsy in dogs with primary intracranial neoplasia.</pubmed_title><pmcid>PMC7517515</pmcid><funding_grant_id>R01CA139099</funding_grant_id><funding_grant_id>R01CA213423</funding_grant_id><funding_grant_id>P30 CA012197</funding_grant_id><funding_grant_id>P01CA207206</funding_grant_id><funding_grant_id>R01 CA213423</funding_grant_id><funding_grant_id>P01 CA207206</funding_grant_id><funding_grant_id>ACVIM Advanced Clinical Training Fellowship</funding_grant_id><pubmed_authors>Shinn RL</pubmed_authors><pubmed_authors>Hsu FC</pubmed_authors><pubmed_authors>Rossmeisl JH</pubmed_authors><pubmed_authors>Kani Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk factors for adverse events occurring after recovery from stereotactic brain biopsy in dogs with primary intracranial neoplasia.</name><description>&lt;h4>Background&lt;/h4>Stereotactic brain biopsy (SBB) allows for histopathologic diagnosis of brain tumors. Adverse events (AE) occur in 5 to 29% of dogs after SBB, but risk factors associated with developing AE are poorly described.&lt;h4>Objective&lt;/h4>Identify clinicopathologic, diagnostic imaging, or procedural variables that are associated with AE in dogs after SBB.&lt;h4>Animals&lt;/h4>Twenty-nine dogs with brain tumors.&lt;h4>Methods&lt;/h4>Retrospective, case-control study. Dogs had laboratory investigations performed before SBB, as well as clinical examinations and diagnostic imaging of the brain before and after SBB. Cases experienced AE after SBB including transient exacerbation of preexisting neurologic deficits, transient new deficits, or permanent neurologic deficits. Controls had SBB performed</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2026-07-15T21:39:54.389Z</modification><creation>2020-10-08T07:21:08Z</creation></dates><accession>S-EPMC7517515</accession><cross_references><pubmed>32924201</pubmed><doi>10.1111/jvim.15885</doi></cross_references></HashMap>